Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Profound Medical | PROF | Dec 24, 2024 | 6.98 | -0.29 |
ProFrac A | ACDC | Dec 24, 2024 | 7.35 | +2.37 |
PROG | PRG | Dec 24, 2024 | 42.51 | +1.87 |
Progress Software | PRGS | Dec 24, 2024 | 66.26 | +1.49 |
Progressive | PGR | Dec 24, 2024 | 243.24 | +0.93 |
Progyny | PGNY | Dec 24, 2024 | 14.53 | +0.28 |
ProKidney | PROK | Dec 24, 2024 | 1.78 | +5.33 |
Prologis | PLD | Dec 24, 2024 | 104.70 | +0.54 |
ProMIS Neurosciences | PMN | Dec 24, 2024 | 0.91 | -1.63 |
PropertyGuru | PGRU | Dec 24, 2024 | 6.70 | 0.00 |
ProPetro | PUMP | Dec 24, 2024 | 9.00 | +0.90 |
ProPhase Labs | PRPH | Dec 24, 2024 | 0.63 | -0.57 |
ProQR Therapeutics | PRQR | Dec 24, 2024 | 2.67 | 0.00 |
PROS | PRO | Dec 24, 2024 | 22.55 | +0.18 |
ProShares Bitcoin Strategy ETF | BITO | Dec 24, 2024 | 24.25 | +6.64 |
Proshares Ultra FTSE Europe | UPV | Dec 24, 2024 | 55.50 | +0.93 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Dec 24, 2024 | 48.12 | -5.46 |
Proshares Ultrashort FTSE Europe | EPV | Dec 24, 2024 | 40.86 | -0.76 |
Prospect Capital | PSEC | Dec 24, 2024 | 4.36 | +4.81 |
Prospect Capital A Pref | PSEC-A | Dec 24, 2024 | 17.93 | +0.06 |
Prosperity Bancshares | PB | Dec 24, 2024 | 76.19 | +0.66 |
Protagenic Therapeutics | PTIX | Dec 24, 2024 | 0.49 | -8.01 |
Protagonist Therapeutics | PTGX | Dec 24, 2024 | 39.30 | -3.20 |
Protalix Bio Therapeutics | PLX | Dec 24, 2024 | 1.78 | +2.89 |
Protara Therapeutics | TARA | Dec 24, 2024 | 5.17 | +0.39 |
Prothena | PRTA | Dec 24, 2024 | 15.40 | +0.46 |
Proto Labs | PRLB | Dec 24, 2024 | 40.03 | +1.01 |
Provident Bancorp | PVBC | Dec 24, 2024 | 11.55 | +1.40 |
Provident Financial | PROV | Dec 24, 2024 | 16.20 | -0.74 |
Provident Financial Services | PFS | Dec 24, 2024 | 19.14 | +0.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.